A rare genetic disorder called infantile hypercalcemia type 1 can appear in adults as recurrent kidney stones and may be treatable with fluconazole, according to a 2026 case report in Frontiers in Medicine. Gram Research analysis of three adult patients with CYP24A1 gene mutations showed that fluconazole successfully lowered dangerous vitamin D levels and reduced kidney damage. This finding suggests doctors should test adults with unexplained kidney stones for this genetic condition.
Researchers discovered that a rare genetic disorder affecting how the body processes vitamin D can show up in adults as recurring kidney stones, not just in babies. The condition, called infantile hypercalcemia type 1, happens when a faulty gene prevents the body from breaking down excess vitamin D. Three adult patients with this condition were successfully treated with fluconazole, a medication typically used to fight fungal infections. This case report suggests doctors should test adults with unexplained kidney stones and high calcium levels for this genetic disorder, opening a new treatment path for people who have struggled with recurrent kidney problems.
Key Statistics
A 2026 case report in Frontiers in Medicine documented three adult patients with infantile hypercalcemia type 1 caused by CYP24A1 gene mutations, all of whom showed improvement in vitamin D levels and kidney function after fluconazole treatment.
All three adult patients in the case series presented with recurrent nephrolithiasis and nephrocalcinosis, demonstrating that this rare genetic disorder previously thought to be primarily infantile can persist undiagnosed into adulthood.
The three patients treated with fluconazole showed normalization of calcium levels and reduced kidney stone formation, suggesting the antifungal medication may effectively manage this genetic vitamin D metabolism disorder in adults.
The Quick Take
- What they studied: Whether a rare genetic disease that usually affects babies could appear in adults and whether a common antifungal drug could treat it
- Who participated: Three adult patients: two women and one man, all dealing with repeated kidney stones and calcium buildup in their kidneys
- Key finding: All three patients had a genetic mutation in the CYP24A1 gene that prevented their bodies from properly breaking down vitamin D, and all three improved with fluconazole treatment
- What it means for you: If you have recurring kidney stones and high calcium levels that doctors can’t explain, genetic testing might reveal this treatable condition. However, this is extremely rare, so your doctor would need to rule out more common causes first
The Research Details
This research presents three detailed case reports of adult patients with a rare genetic disorder. The doctors carefully documented each patient’s medical history, test results, and response to treatment with fluconazole. Case reports are detailed stories of individual patients rather than large studies, making them useful for identifying rare diseases and new treatment approaches that doctors might not have considered before.
The researchers traced each patient’s symptoms back to mutations in the CYP24A1 gene. This gene normally produces an enzyme that acts like a cleanup crew for vitamin D in your body. When this gene is broken, vitamin D builds up to dangerous levels, causing calcium to accumulate in the blood and kidneys. The doctors measured vitamin D levels, calcium levels, and kidney function before and after treatment to track improvements.
This type of case report is valuable because it alerts the medical community to rare conditions that might be hiding in plain sight. Many adults with this genetic disorder may have been misdiagnosed as having common kidney stone disease, when actually they had this treatable genetic condition all along.
Case reports like this one are detective work in medicine. They help doctors recognize patterns they might otherwise miss. By documenting these three cases, the researchers are essentially saying: if you see an adult with unexplained kidney stones and high calcium, think about genetic testing. This could change how thousands of patients are diagnosed and treated.
This is a case report, which means it describes real patients but doesn’t compare them to a control group. Case reports are lower on the evidence ladder than large studies, but they’re valuable for spotting rare diseases and new treatments. The strength here is that all three patients improved with the same treatment, suggesting the approach works. The limitation is that three cases can’t prove the treatment works for everyone with this condition. More research with larger groups would be needed to confirm these findings.
What the Results Show
All three patients had the same genetic mutation in the CYP24A1 gene, which prevented their bodies from properly breaking down a form of vitamin D called 1,25-dihydroxyvitamin D3. This caused vitamin D and calcium to build up to dangerous levels in their blood and kidneys. Two of the patients were women who came to the doctor complaining of repeated kidney stones. The third patient was a man who had shown symptoms as a baby but wasn’t diagnosed until adulthood.
When the doctors started treating all three patients with fluconazole, something remarkable happened: their vitamin D levels dropped, their calcium levels normalized, and their kidney function improved. Fluconazole is normally used to treat fungal infections, but it appears to work here by blocking the enzyme that produces excess vitamin D. The patients experienced fewer kidney stone episodes and less kidney damage after starting treatment.
One important finding was that some of these patients also developed a secondary kidney problem called distal renal tubular acidosis, where the kidneys can’t properly regulate acid in the body. This complication improved with fluconazole treatment as well. The case report emphasizes that this genetic disorder can hide in adults for years, causing repeated kidney problems that doctors might attribute to other causes.
The research revealed that this genetic disorder can present differently depending on when it appears. The two adult women had milder forms that only became obvious when they developed recurrent kidney stones. The male patient had more severe symptoms starting in infancy but wasn’t properly diagnosed until adulthood. This variation suggests that some people with this genetic mutation may go undiagnosed for decades, suffering from preventable kidney damage. The report also noted that kidney function varied among the three patients, with some showing more damage than others before treatment began.
Infantile hypercalcemia type 1 was previously thought to be primarily a disease of infants and young children. This case report expands our understanding by showing that milder forms can persist into adulthood, where they masquerade as common kidney stone disease. Previous research identified the genetic cause and showed that vitamin D levels are abnormally high, but this is one of the first reports demonstrating that fluconazole can effectively treat the condition in adults. The finding aligns with basic science research showing that fluconazole can interfere with vitamin D metabolism, but clinical confirmation in real patients is important.
This case report describes only three patients, so we can’t be certain the results would apply to everyone with this genetic disorder. The patients were followed for a limited time period, so we don’t know if fluconazole remains effective long-term or if side effects might develop. The report doesn’t include a comparison group of untreated patients, so we can’t be completely sure the improvement was due to fluconazole rather than other factors. Additionally, this is an extremely rare condition, so it may take years to gather enough cases to fully understand how common it is and how best to treat it. The report also doesn’t specify exactly how long each patient was followed after starting treatment.
The Bottom Line
If you have recurrent kidney stones and your doctors can’t find a clear reason, ask about genetic testing for CYP24A1 mutations. This is especially important if you also have high calcium levels in your blood. If you’re diagnosed with this condition, fluconazole appears to be an effective treatment option, though more research is needed. Work closely with a nephrologist (kidney specialist) and genetic counselor to monitor your condition and adjust treatment as needed. Confidence level: moderate, based on three successful cases but limited by the small sample size.
Adults with unexplained recurrent kidney stones should pay attention to this research, especially if standard treatments haven’t worked well. People with a family history of kidney stones or genetic kidney disease might benefit from knowing about this possibility. Doctors who treat kidney stone patients should consider this diagnosis in cases that don’t fit the typical pattern. This research is less relevant for people with one or two kidney stones in their lifetime, as this genetic condition typically causes repeated episodes.
Based on these three cases, patients showed improvement in vitamin D and calcium levels within weeks to months of starting fluconazole. Kidney function improvements and reduction in kidney stone formation took longer, typically several months. However, with only three patients and limited follow-up data, we can’t say exactly how long it takes for full improvement or whether benefits continue long-term.
Frequently Asked Questions
Can you get infantile hypercalcemia as an adult?
Yes, according to a 2026 case report, milder forms of infantile hypercalcemia type 1 can go undiagnosed until adulthood, when patients typically present with recurrent kidney stones. The genetic mutation is present from birth but may not cause severe symptoms until later in life.
What causes infantile hypercalcemia type 1?
Infantile hypercalcemia type 1 results from mutations in the CYP24A1 gene, which normally produces an enzyme that breaks down vitamin D. Without this enzyme working properly, vitamin D builds up to toxic levels, causing calcium to accumulate dangerously in the blood and kidneys.
Can fluconazole treat kidney stones from genetic disorders?
In a 2026 case report, fluconazole successfully treated three adult patients with infantile hypercalcemia type 1, reducing vitamin D levels and improving kidney function. However, this is an extremely rare condition, and fluconazole is not a standard kidney stone treatment for most patients.
How do doctors diagnose infantile hypercalcemia in adults?
Doctors diagnose this condition through genetic testing for CYP24A1 mutations, combined with blood tests showing high calcium and vitamin D levels. It’s typically suspected in adults with unexplained recurrent kidney stones and high calcium that don’t respond to standard treatments.
Is infantile hypercalcemia type 1 common?
No, infantile hypercalcemia type 1 is extremely rare. The 2026 case report highlights only three adult cases, suggesting many people with this genetic mutation may go undiagnosed and misdiagnosed as having common kidney stone disease instead.
Want to Apply This Research?
- Log any kidney stone episodes, noting the date, severity, and any symptoms. Also track your calcium and vitamin D levels from lab work when available. This creates a pattern that can help your doctor determine if treatment is working.
- If diagnosed with this condition, set reminders to take fluconazole as prescribed and schedule regular blood tests to monitor calcium and vitamin D levels. Keep detailed records of any kidney-related symptoms to share with your doctor at appointments.
- Track kidney stone frequency month-to-month and compare to baseline. Monitor lab results for calcium and vitamin D levels every 3 to 6 months. Note any changes in urinary symptoms or kidney function tests. Share this data with your nephrologist to assess whether treatment adjustments are needed.
This case report describes three individual patients and should not be considered proof that fluconazole works for everyone with this genetic condition. If you have recurrent kidney stones or high calcium levels, consult with a nephrologist or your primary care doctor before pursuing genetic testing or considering fluconazole treatment. This research is extremely preliminary and based on a very small number of cases. Do not start, stop, or change any medications without medical supervision. Infantile hypercalcemia type 1 is a serious medical condition requiring professional diagnosis and ongoing medical management.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.